Back to Clinical Trials
Phase 3Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Sponsored by Bristol-Myers Squibb

About this study

The purpose of this study is to evaluate the efficacy of Pumitamig versus Pembrolizumab in participants with previously untreated advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%.

Where this study is enrolling (22)

  • Southern Cancer Center Pc

    Daphne, Alabama

    Call 111-111-1111

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Palo Verde Hematology Oncology

    Glendale, Arizona

    Call +1 602-978-6255

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • BASS Cancer Center

    Walnut Creek, California

    Call 916-734-3771

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Beverly Hills Cancer Center

    Beverly Hills, California

    Call 310-432-8955

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Pacific Cancer Care

    Monterey, California

    Call 831-375-4105

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

Show all 22 locations

  • Orange Coast Memorial Medical Center

    Fountain Valley, California

    Call 510673-1293

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Florida Clinical Trials Group

    Tamarac, Florida

    Call 561-447-0614

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Clermont Oncology Center

    Clermont, Florida

    Call 352-242-1366

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • BRP- Hialeah Hospital

    Hialeah, Florida

    Call 833-489-4968

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Advanced Research

    Coral Springs, Florida

    Call 954-302-3120

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital

    Marietta, Georgia

    I'm interested

  • University Cancer & Blood Center, LLC

    Athens, Georgia

    Call 706-353-2990

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Northwest Cancer Centers, P.C.

    Dyer, Indiana

    Call 219-924-8178

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Optum Medical Care, PC

    Westbury, New York

    Call 914-242-2991

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Memorial Sloan Kettering Cancer Center

    New York, New York

    Call 617-632-3468

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Novant Health Pharmacy Oncology Specialists

    Winston-Salem, North Carolina

    Call 336-209-0239

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Lancaster General Hospital

    Lancaster, Pennsylvania

    Call 717-215-9561

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • WellSpan Oncology Research

    York, Pennsylvania

    Call 717-339-2560

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • University Of Texas Medical Branch At Galveston

    Galveston, Texas

    Call 409-772-1164

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Kelsey-Seybold Clinic Main Campus

    Houston, Texas

    Call 713-442-0000

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Texas Oncology - San Antonio

    San Antonio, Texas

    Call 210-656-7177

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • HSHS St. Vincent Hospital Regional Cancer Center

    Green Bay, Wisconsin

    Call 920-884-3135

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

Who can participate

Inclusion criteria

  • ✓Participants must have a histologically or cytologically confirmed diagnosis of Non-Small Cell Lung Cancer (NSCLC) (squamous and nonsquamous) with Stage IIIB/IIIC or Stage IV disease.
  • ✓Participants must have a programmed death ligand-1 (PD-L1) expression ≥ 50%.
  • ✓Participants must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.
  • ✓Participants must have no prior systemic anti-tumor therapy for locally advanced or metastatic NSCLC.
  • ✓Participants must have an Eastern Cooperative Oncology Group (ECOG) Performance Status 0-1.

Exclusion criteria

  • ✕Participants must not have any documented actionable genomic alteration (AGA) for which first-line (1L) approved therapies are indicated.
  • ✕Participants must not have any symptomatic untreated central nervous system (CNS) metastases, leptomeningeal metastases (carcinomatous meningitis) or spinal cord compression.
  • ✕Participants must not have any significant cardiovascular impairment as evidenced by uncontrolled hypertension (despite optimal medical treatment), congestive heart failure, active coronary disease (within 6 months prior to randomization), ventricular arrhythmias, or major thrombotic or embolic events or major hemorrhagic events (within 6 months prior to randomization), or significant risk of pulmonary hemorrhage.
  • ✕Participants must not an active autoimmune disease.
  • ✕Other protocol-defined Inclusion/Exclusion criteria apply.

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.